Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 16;363(6):1638-1645.
doi: 10.1002/adsc.202001279. Epub 2021 Feb 3.

Construction of N-Boc-2-Alkylaminoquinazolin-4(3 H)-Ones via a Three-Component, One-Pot Protocol Mediated by Copper(II) Chloride that Spares Enantiomeric Purity

Affiliations

Construction of N-Boc-2-Alkylaminoquinazolin-4(3 H)-Ones via a Three-Component, One-Pot Protocol Mediated by Copper(II) Chloride that Spares Enantiomeric Purity

Xiaoyu Li et al. Adv Synth Catal. .

Abstract

Chiral 2-alkylquinazolinones are key synthetic intermediates, but their preparation in high optical purity is challenging. Thus, a multicomponent procedure integrating anthranilic acids, N-Boc-amino acids, and amines in the presence of methanesulfonyl chloride, N-methylimidazole, and copper(II) chloride was developed to mildly afford N-Boc-2-alkylaminoquinazolin-4(3H)-ones with excellent preservation of enantiomeric purity (>99% ee). Copper(II) chloride was essential to retaining enantiopurity, and reaction component structural changes were well tolerated, resulting in an efficient, all-in-one procedure that promotes sequential coupling, lactonization, aminolysis, and cyclization in good yields. The method was applied to the rapid assembly of four key intermediates used in the synthesis of high profile quinazolinones, including several PI3K inhibitor drugs.

Keywords: PI3 kinase; copper-mediated; enantiopurity; quinazolinone; racemization.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selected 2‐alkylaminoquinazolin‐4(3H)‐ones.
Scheme 1
Scheme 1
General synthetic approaches to N‐Boc‐quinazolinones.
Scheme 2
Scheme 2
Exploratory chemistry leading to 12 a formation.
Scheme 3
Scheme 3
Formal syntheses of acalisib 3, ispinesib 4 and quinazolinone 5 using the one‐pot procedure on a 1.0 mmol scale (0.07 M). Yields reflect isolated product and %ee was determined by chiral HPLC comparison of peak AUCs.
Scheme 4
Scheme 4
Control experiments revealing need for CuCl2.
Scheme 5
Scheme 5
Proposed role of CuCl2 in attenuating racemization.

Similar articles

Cited by

References

    1. None
    1. Resende D. I. S. P., Boonpothong P., Sousa E., Kijjoa A., Pinto M. M. M., Nat. Prod. Rep. 2019, 36, 7–34; - PubMed
    1. Khan I., Ibrar A., Ahmed W., Saeed A., Eur. J. Med. Chem. 2015, 90, 124–169; - PubMed
    1. Kshirsagar U. A., Org. Biomol. Chem. 2015, 13, 9336–9352; - PubMed
    1. Demeunynck M., Baussanne I., Curr. Med. Chem. 2013, 20, 794–814; - PubMed

LinkOut - more resources